Jury Awards $1.3M In Zometa Jaw Injury Trial After Botching 1st Verdict Form

ORLANDO, Fla. - A Florida federal jury on Sept. 20 found that Novartis Pharmaceuticals Corp. failed to warn a cancer patient about the risk of osteonecrosis of the jaw (ONJ) and awarded her $1.3 million in medical expenses and non-economic damages (Nancy Guenther, et al. v. Novartis Pharmaceutical Corporation, No. 6:08-456, M.D. Fla., Orlando Div.).

Access this news story on lexis.com®